These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16675171)

  • 1. Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance?
    Trinh XB; van Dam PA; Tjalma WA
    Maturitas; 2006 Aug; 55(1):94-5; author reply 96-7. PubMed ID: 16675171
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
    Sinha A; Nwosu EC
    J Obstet Gynaecol; 2002 Nov; 22(6):695. PubMed ID: 12554277
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
    Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W
    Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.
    Peled Y; Perri T; Pardo Y; Kaplan B
    Menopause; 2007; 14(3 Pt 1):550-4. PubMed ID: 17224852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity to Mirena--a rare complication.
    Pereira A; Coker A
    J Obstet Gynaecol; 2003 Jan; 23(1):81. PubMed ID: 12647710
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case report. Sepsis in connection with levonorgestrel IUD].
    Ottander U; Bäckström T; Högberg U; Löfgren M
    Lakartidningen; 1995 Nov; 92(48):4555-7. PubMed ID: 7490972
    [No Abstract]   [Full Text] [Related]  

  • 7. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting progestogen contraceptives.
    Power J; Guillebaud J
    Practitioner; 2002 May; 246(1634):332, 335-9, 341. PubMed ID: 12043350
    [No Abstract]   [Full Text] [Related]  

  • 9. Menopausal symptoms.
    Koratamaddi LP; Prasad M
    N Engl J Med; 2007 Mar; 356(11):1177; author reply 1177-8. PubMed ID: 17361492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arterial hypertension, menopause and hormone substitution].
    Gannage-Yared MH; Atallah C; Jambart S
    J Med Liban; 2000; 48(6):387-91. PubMed ID: 11503532
    [No Abstract]   [Full Text] [Related]  

  • 11. Routes of delivery for progesterone and progestins.
    Sitruk-Ware R
    Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and progesterone replacement in perimenopause and menopause: the urogenital system and sexuality].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Aug; 86(33):1243-4. PubMed ID: 9381008
    [No Abstract]   [Full Text] [Related]  

  • 13. Menorrhagia and 3-keto-desogestrel-copper medicated intrauterine device.
    Janssen CA
    Eur J Obstet Gynecol Reprod Biol; 1999 Aug; 85(2):135-6. PubMed ID: 10610326
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-menopausal oestrogen-progestogen therapy.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 72():531-628. PubMed ID: 10533180
    [No Abstract]   [Full Text] [Related]  

  • 15. Editor's Choice: menorrhagia and endometrial ablation.
    Guillebaud J
    Br J Obstet Gynaecol; 1998 Jul; 105(7):809. PubMed ID: 9692427
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term use of the levonorgestrel-releasing intrauterine system.
    Inki P
    Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
    Kresowik J; Ryan GL; Van Voorhis BJ
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
    Mansour D
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement Up-to-date. Effect of estrogen therapy (EP) and estrogen-progestogen therapy (EPT) on the bone metabolism].
    Taniguchi R; Higuchi T; Mizunuma H
    Clin Calcium; 2007 Sep; 17(9):1342-8. PubMed ID: 17767022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.